| Novel delivery strategies for glioblastoma J Zhou, KB Atsina, BT Himes, GW Strohbehn, WM Saltzman The Cancer Journal 18 (1), 89-99, 2012 | 141 | 2012 |
| Active Notch1 confers a transformed phenotype to primary human melanocytes CC Pinnix, JT Lee, ZJ Liu, R McDaid, K Balint, LJ Beverly, PA Brafford, ... Cancer research 69 (13), 5312-5320, 2009 | 133 | 2009 |
| Treatment strategies in diffuse midline gliomas with the H3K27M mutation: the role of convection-enhanced delivery in overcoming anatomic challenges BT Himes, L Zhang, DJ Daniels Frontiers in oncology 9, 31, 2019 | 110 | 2019 |
| Contemporary analysis of the intraoperative and perioperative complications of neurosurgical procedures performed in the sitting position BT Himes, GW Mallory, AS Abcejo, J Pasternak, JLD Atkinson, FB Meyer, ... Journal of neurosurgery 127 (1), 182-188, 2016 | 83 | 2016 |
| Immunosuppression in glioblastoma: current understanding and therapeutic implications BT Himes, PA Geiger, K Ayasoufi, AG Bhargav, DA Brown, IF Parney Frontiers in Oncology 11, 770561, 2021 | 81 | 2021 |
| Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status L Sigalotti, A Covre, S Zabierowski, B Himes, F Colizzi, PG Natali, ... Journal of cellular physiology 215 (2), 287-291, 2008 | 77 | 2008 |
| Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report BT Himes, MW Ruff, JJ Van Gompel, SS Park, E Galanis, TJ Kaufmann, ... Journal of neurosurgery 130 (4), 1299-1303, 2018 | 72 | 2018 |
| The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction BT Himes, TE Peterson, T de Mooij, LMC Garcia, MY Jung, S Uhm, D Yan, ... Neuro-oncology 22 (7), 967-978, 2020 | 69 | 2020 |
| Direct reprogramming of melanocytes to neural crest stem-like cells by one defined factor SE Zabierowski, V Baubet, B Himes, L Li, M Fukunaga-Kalabis, S Patel, ... Stem Cells 29 (11), 1752-1762, 2011 | 65 | 2011 |
| Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators K Ayasoufi, CK Pfaller, L Evgin, RH Khadka, ZP Tritz, EN Goddery, ... Brain 143 (12), 3629-3652, 2020 | 50 | 2020 |
| Insurance correlates with improved access to care and outcome among glioblastoma patients DA Brown, BT Himes, P Kerezoudis, YM Chilinda-Salter, SS Grewal, ... Neuro-oncology 20 (10), 1374-1382, 2018 | 41 | 2018 |
| Ventriculostomy and risk of upward herniation in patients with obstructive hydrocephalus from posterior fossa mass lesions SA Braksick, BT Himes, K Snyder, JJ Van Gompel, JE Fugate, ... Neurocritical care 28, 338-343, 2018 | 23 | 2018 |
| Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience S Cohen-Cohen, DA Brown, BT Himes, LP Wheeler, MW Ruff, BT Major, ... Journal of neurosurgery 1 (aop), 1-7, 2020 | 21 | 2020 |
| Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury RC Puffer, LMC Garcia, BT Himes, MY Jung, FB Meyer, DO Okonkwo, ... Journal of neurosurgery 134 (6), 1921-1928, 2020 | 17 | 2020 |
| Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis DA Brown, VM Lu, BT Himes, TC Burns, A Quinones-Hinojosa, ... Clinical & Experimental Metastasis 37, 341-352, 2020 | 16 | 2020 |
| Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1 MY Jung, A Aibaidula, DA Brown, BT Himes, LM Cumba Garcia, IF Parney Neuro-Oncology Advances 4 (1), vdac017, 2022 | 15 | 2022 |
| Cranial tumor surgical outcomes at a high-volume academic referral center DA Brown, BT Himes, BT Major, BF Mundell, R Kumar, B Kall, FB Meyer, ... Mayo Clinic Proceedings 93 (1), 16-24, 2018 | 14 | 2018 |
| ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage J Liu, X Wang, AT Chen, X Gao, BT Himes, H Zhang, Z Chen, J Wang, ... Nature communications 13 (1), 2196, 2022 | 11 | 2022 |
| Glioblastoma recurrence versus treatment effect in a pathology-documented series BT Himes, AL Arnett, KW Merrell, MJ Gates, AG Bhargav, A Raghunathan, ... Canadian Journal of Neurological Sciences 47 (4), 525-530, 2020 | 11 | 2020 |
| Does pituitary compression/empty sella syndrome contribute to MRI-negative Cushing’s disease? A single-institution experience BT Himes, AG Bhargav, DA Brown, TJ Kaufmann, I Bancos, ... Neurosurgical focus 48 (6), E3, 2020 | 11 | 2020 |
Ian ParneyMayo Clinic在 mayo.edu 的电子邮件经过验证
